Avantor Performance Materials announced the expansion of its distribution arrangement with VWR International, LLC. The agreement was for expanded distribution of Avantor's pharmaceutical production and chemicals portfolio in the Middle East, Europe and Africa (EMEA) region.
"The expansion of our access to VWR's global distribution capabilities and infrastructure allows both companies to significantly enhance their sales and marketing presence in the region," said Paul Smaltz, Executive Vice President of Pharmaceuticals for Avantor.
"We anticipate strong sales growth in the biopharmaceutical and pharmaceutical industry in the EMEA region over the next several years, combined with an enhanced ability to better serve the customer needs, through VWR's supply chain capabilities," Smaltz added.
"VWR is very pleased to expand its current arrangement with Avantor to support our customers with its quality products. This, combined with VWR's 160 years of experience, will bring significant value to our customers and support their production needs," said Manuel Brocke-Benz, VWR's President and CEO.
VWR is a leading global solutions provider of laboratory equipment, supplies and services.
Avantor is a global resource catering to biopharmaceutical and pharmaceutical manufacturers worldwide. The company supplies high quality ingredients, bio buffers, processing agents, nutrients and excipients.
Join the Conversation